SCOCCHI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 9.827
AS - Asia 4.697
EU - Europa 4.366
SA - Sud America 592
AF - Africa 147
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 17
Totale 19.664
Nazione #
US - Stati Uniti d'America 9.670
SG - Singapore 1.646
CN - Cina 1.222
IT - Italia 860
SE - Svezia 735
PL - Polonia 670
BR - Brasile 487
VN - Vietnam 458
HK - Hong Kong 432
UA - Ucraina 426
DE - Germania 296
FR - Francia 260
KR - Corea 236
GB - Regno Unito 229
FI - Finlandia 228
RU - Federazione Russa 177
TR - Turchia 161
BD - Bangladesh 136
BG - Bulgaria 99
IN - India 99
IE - Irlanda 89
CA - Canada 82
NL - Olanda 81
JP - Giappone 57
CH - Svizzera 55
MA - Marocco 48
MX - Messico 42
AR - Argentina 41
IQ - Iraq 34
ZA - Sudafrica 31
BE - Belgio 30
ES - Italia 25
PT - Portogallo 24
PK - Pakistan 21
SN - Senegal 20
SA - Arabia Saudita 19
AT - Austria 18
ID - Indonesia 18
UZ - Uzbekistan 18
MY - Malesia 17
EU - Europa 14
PH - Filippine 14
TW - Taiwan 14
AU - Australia 13
CZ - Repubblica Ceca 12
PE - Perù 12
EC - Ecuador 11
EG - Egitto 11
KE - Kenya 11
VE - Venezuela 11
TH - Thailandia 10
AE - Emirati Arabi Uniti 9
CO - Colombia 9
IL - Israele 9
HR - Croazia 8
KZ - Kazakistan 8
RO - Romania 8
DZ - Algeria 7
NP - Nepal 7
PY - Paraguay 7
AZ - Azerbaigian 6
CL - Cile 6
GE - Georgia 6
CR - Costa Rica 5
DK - Danimarca 5
NZ - Nuova Zelanda 5
BH - Bahrain 4
ET - Etiopia 4
GT - Guatemala 4
JM - Giamaica 4
JO - Giordania 4
KG - Kirghizistan 4
OM - Oman 4
PA - Panama 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
AL - Albania 3
GR - Grecia 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
LK - Sri Lanka 3
LT - Lituania 3
MN - Mongolia 3
NI - Nicaragua 3
RS - Serbia 3
SI - Slovenia 3
TN - Tunisia 3
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
DM - Dominica 2
DO - Repubblica Dominicana 2
LU - Lussemburgo 2
MD - Moldavia 2
ML - Mali 2
NG - Nigeria 2
NO - Norvegia 2
PS - Palestinian Territory 2
QA - Qatar 2
Totale 19.635
Città #
Singapore 1.073
Woodbridge 994
Ashburn 972
Fairfield 913
Ann Arbor 787
Houston 694
Chandler 613
Warsaw 564
San Jose 448
Hong Kong 420
Wilmington 410
Jacksonville 392
Seattle 328
Cambridge 325
Trieste 325
Beijing 324
Seoul 233
Hefei 220
Princeton 172
Boardman 170
Los Angeles 146
Ho Chi Minh City 137
Chicago 123
Dallas 122
Izmir 121
Hanoi 113
Columbus 100
Sofia 98
Dublin 89
Lauterbourg 88
Santa Clara 86
Zgierz 85
Helsinki 84
Milan 74
Dearborn 73
New York 72
Frankfurt am Main 69
Moscow 69
The Dalles 67
Buffalo 65
Council Bluffs 61
London 53
Porto Alegre 53
Düsseldorf 50
São Paulo 46
San Diego 45
Casablanca 43
Munich 39
Tokyo 36
Nanjing 34
Shanghai 32
Bern 30
Orem 29
Rio de Janeiro 27
Brussels 25
Des Moines 25
Falls Church 25
Nuremberg 25
Redmond 23
Guangzhou 22
Toronto 22
Brooklyn 21
Kunming 21
Phoenix 21
Dakar 20
Louriçal 20
Sacile 20
Da Nang 19
Pune 19
Zurich 19
Amsterdam 18
Ottawa 18
Tashkent 18
Verona 18
Hangzhou 17
Johannesburg 17
Stockholm 17
Dong Ket 16
Haiphong 16
Miano 16
Denver 15
Jinan 15
Montreal 15
Washington 15
Chennai 14
Manchester 14
Norwalk 14
Atlanta 13
Baghdad 13
North Bergen 13
Redondo Beach 13
Turku 13
Redwood City 12
Changsha 11
Kocaeli 11
Mexico City 11
Nairobi 11
Paris 11
Shenyang 11
Taipei 11
Totale 13.610
Nome #
Arabica coffee extract shows antibacterial activity against Staphylococcus epidermidis and Enterococcus faecalis and low toxicity towards a human cell line 525
D-BMAP18 antimicrobial peptide is active In Vitro, resists to pulmonary proteases but loses its activity in a murine model of Pseudomonas aeruginosa lung infection 383
Structure of the mammalian antimicrobial peptide Bac7(1-16) bound within the exit tunnel of a bacterial ribosome 373
Proline-rich antimicrobial peptides targeting protein synthesis 361
Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7 332
The human cathelicidin LL-37 - A pore-forming antibacterial peptide and host-cell modulator 324
Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients 295
Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. 292
An appraoch combining rapid cDNA amplification and chemical synthesis for the identification of novel, cathelicidin-derived, antimicrobial peptides. 279
Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA. 275
Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes. 267
A synthetic approach for a SAR study of the Pro- and Arg-rich bactenecin bac7. 266
Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates 261
An approach combining rapid cDNA amplification and chemical synthesis for the identification of novel, cathelicidin-derived, antimicrobial peptides. 257
Sub-Mic effects of a proline-rich antibacterial peptide on clinical isolates of Acinetobacter baumannii 254
Induced expression of cathelicidins in trout (Oncorhynchus mykiss) challenged with four different bacterial pathogens 248
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 248
PEGylation of the peptide Bac7(1–35) reduces renal clearance while retaining antibacterial activity and bacterial cell penetration capacity 247
Non-Membrane Permeabilizing Modes of Action of Antimicrobial Peptides on Bacteria 246
The mechanism of killing by the proline-rich peptide Bac7(1-35) against clinical strains of Pseudomonas aeruginosa differs from that against other gram-negative bacteria 244
Dual mode of action of Bac7, a proline-rich antibacterial peptide 241
Biological characterization of a novel mammalian antimicrobial peptide. 241
Novel cathelicidins in horse leukocytes 240
PMAP-37, a novel antibacterial peptide from pig myeloid cells: c-DNA cloning, chemical synthesis and activity 240
Cellular Internalization and Cytotoxicity of the Antimicrobial Proline-rich Peptide Bac7(1-35) in Monocytes/Macrophages, and its Activity Against Phagocytosed Salmonella Typhimurium 240
cDNA sequences of three sheep myeloid cathelicidins. 238
Antimicrobial and host cell-directed activities of Gly/Ser-rich peptides from salmonid cathelicidins 234
Functional and structural study of the dimeric inner membrane protein SbmA. 233
Proteolytic Activity of Escherichia coli Oligopeptidase B Against Proline-Rich Antimicrobial Peptides. 231
Methods for elucidating the mechanism of action of proline-rich and other non-lytic antimicrobial peptides 227
Enteric YaiW is a surface-exposed outer membrane lipoprotein that affects sensitivity to an antimicrobial peptide. 226
Proteolytic cleavage by neutrophil elastase converts inactive storage proforms to antibacterial bactenecins. 225
Structural aspects of plant antimicrobial peptides 220
Cathelicidins: An Ancient Family of Fish Antimicrobial Peptides 218
Role of Cathelicidin Peptides in Bovine Host Defense and Healing 216
Structural and functional analysis of horse cathelicidin peptides 215
Cathelicidin-derived antimicrobial peptides: in vitro and in vivo activity 214
BacA is essential for bacteroid development in nodules of galegoid, but not phaseoloid, legumes 214
Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1–25) That Retain Antimicrobial Activity by Blocking Protein Synthesis 212
Single Cell Flow Cytometry Assay for Peptide Uptake by Bacteria 211
Cloning and analysis of a transcript derived from two contiguous genes of the cathelicidin family. 210
Rapid and reliable detection of antimicrobial peptide penetration into Gram-negative bacteria based on fluorescence quenching. 210
Structure and biology of cathelicidins 209
Peptide Inhibitors of Bacterial Protein Synthesis with Broad Spectrum and SbmA-Independent Bactericidal Activity against Clinical Pathogens 207
Synthetic approach to the identification of the antibacterial domain of bactenecins, Pro/Arg rich peptides from bovine neutrophils. 204
Proline-rich Antimicrobial Peptides: Converging to a Non-Lytic Mechanism of Action. 204
Variazioni di suscettibilità ad antibiotici e al peptide BMAP-27 in isolati multipli di P. aeruginosa ottenuti da pazienti con fibrosi cistica 204
Inner membrane proteins YgdD and SbmA are required for the complete susceptibility of escherichia coli to the proline-rich antimicrobial peptide arasin 1(1–25) 202
Antimicrobial activity of two bactenecins against spirochetes. 201
NMR structural characterization of the reaction product between d(GpG) and the octahedral antitumor complex trans-RuCl2(DMSO)4. 200
Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts 198
Functional characterization of SbmA, a bacterial inner membrane transporter required for importing the antimicrobial peptide Bac7(1-35). 197
Molecular cloning and chemical synthesis of a novel antibacterial peptide derived from pig myeloid cells. 196
Structural organization of the bovine cathelicidin gene family and identification of a novel member. 196
Structural aspects and biological properties of the cathelicidin PMAP-36 192
Six antimicrobial peptide genes of the cathelicidin family map to bovine chromosome 22q24 by fluorescence in situ hybridization. 191
Synthesis and characterization of a novel pig antibacterial peptide deduced from cDNA. 190
The anti-pseudomonal peptide d-bmap18 is active in cystic fibrosis sputum and displays anti-inflammatory in vitro activity 183
Molecular cloning of Bac7, a proline- and arginine-rich antimicrobial peptide from bovine neutrophils. 180
Genome-wide Transcriptional profiling of the Escherichia coli response to a Proline-rich antimicrobial peptide 179
Cathelicidins—a rich seam of antimicrobial peptides waiting for exploitation 177
Lipopolysaccharide phosphorylation by the WaaY kinase affects the susceptibility of Escherichia coli to the human antimicrobial peptide LL-37 176
Fragments of the nonlytic proline-rich antimicrobial peptide Bac5 kill Escherichia coli cells by inhibiting protein synthesis 176
Partial Complementation of Sinorhizobium meliloti bacA Mutant Phenotypes by the Mycobacterium tuberculosis BacA Protein 175
Structure-Activity Relationships of the Antimicrobial Peptide Arasin 1 — And Mode of Action Studies of the N-Terminal, Proline-Rich Region 170
null 169
null 168
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia 165
Characterization of cetacean proline-rich antimicrobial peptides displaying activity against eskape pathogens 165
Structure-activity relationship study on Bac7(1-35), a synthetic fragment of the Pro-rich antibacterial peptide Bac7 163
null 163
Chemical synthesis, structural features and biological activity of novel mammalian antibiotic peptides identified through amplification of homologous cDNA sequences 162
null 160
Effects of lipidation on a proline-rich antibacterial peptide 160
Designing New Hybrid Antibiotics: Proline-Rich Antimicrobial Peptides Conjugated to the Aminoglycoside Tobramycin 159
Elastase-Activated Antimicrobial Peptide for a Safer Pulmonary Treatment of Cystic Fibrosis Infections 156
null 154
Design, antimicrobial activity and mechanism of action of Arg-rich ultra-short cationic lipopeptides 151
Proline-Rich Peptides with Improved Antimicrobial Activity against E. coli, K. pneumoniae, and A. baumannii 144
Novel synthesis of 1,2-diaza-1,3-dienes with potential biological activity from cinnamic acids and diazonium salts of anilines 142
null 138
XVIth scientific meeting of the Italian Association of Developmental and Comparative Immunobiology (IADCI), 18 - 20 February 2015, Department of Life Sciences, University of Trieste, and National Institute of Oceanography and Experimental Geophysics, Trieste, Italy 138
The proline-rich myticalins from Mytilus galloprovincialis display a membrane-permeabilizing antimicrobial mode of action 138
Paenilamicins are context-specific translocation inhibitors of protein synthesis 135
null 127
The proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium in a mouse model of infection. 123
The proline-rich antimicrobial peptide B7-005: low bacterial resistance, safe for human cells and effective in zebrafish embryo bacteraemia model 120
Internalisation of a thiazole-modified peptide in Sinorhizobium meliloti occurs by BacA-dependent and -independent mechanisms. 120
The host antimicrobial peptide Bac71-35 binds to bacterial ribosomal proteins and inhibits protein synthesis 120
Sustainable, Site-Specific Linkage of Antimicrobial Peptides to Cotton Textiles 116
Investigating the Mode of Action of Proline-rich Antimicrobial Peptides Using a Genetic Approach: a Tool to Identify New Bacterial Targets Amenable to the Design of Novel Antibiotics. 110
Natural and synthetic halogenated amino acids—structural and bioactive features in antimicrobial peptides and peptidomimetics 109
Bioactive compounds: a goldmine for defining new strategies against pathogenic bacterial biofilms? 107
Structural and biological characterization of shortened derivatives of the cathelicidin PMAP-36 106
Inducible expression of an antimicrobial peptide of the innate immunity in polymorphonuclear leukocytes. 95
Use of unnatural amino acids to probe structure-activity relationships and mode-of-action of antimicrobial peptides 80
The salmonid cathelicidins: a gene family with highly varied C-terminal antimicrobial domains. 77
New Antimicrobials Targeting Bacterial RNA Polymerase Holoenzyme Assembly Identified with an in Vivo BRET-Based Discovery Platform 75
The Proline-rich Antibacterial Peptide Bac7 Binds to and Inhibits in vitro the Molecular Chaperone DnaK 72
Rational Designed Hybrid Peptides Show up to a 6-Fold Increase in Antimicrobial Activity and Demonstrate Different Ultrastructural Changes as the Parental Peptides Measured by BioSAXS 67
Totale 19.894
Categoria #
all - tutte 53.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 0 0 0 0 0 0 142
2021/20221.196 48 93 82 137 38 93 44 37 137 119 83 285
2022/20231.663 142 237 134 260 149 291 8 157 174 6 74 31
2023/20241.011 70 71 64 76 93 91 200 151 27 21 76 71
2024/20252.457 30 93 307 211 218 287 104 116 317 277 237 260
2025/20265.997 591 329 474 557 506 509 824 186 646 851 317 207
Totale 20.089